Arkus Innovation Studios

Novuson Surgical — Diagnostic

A multi-phase engagement that began with a focused Diagnostic read on the market and investor workflow, then expanded into brand redesign and Series A support.

Novuson prepared for a Series A raise and needed investor-ready positioning, a sharper market narrative, and raise-ready support assets tied to external evidence.

The founders needed external creative and analytical capacity they did not want to stand up in-house during the raise cycle. The engagement was scoped directly to close those gaps.

Brand redesign: Positioning, visual identity, and narrative redesign aligned to investor-facing context.

Series A support: Custom market analysis, investor targeting, pitch material development, and ongoing advisory during the raise cycle.

The engagement operated as custom execution support tailored to Series A readiness. Final financing outcomes and disclosed raise metrics are pending client-approved publication.

Arkus did not act as a placement agent or broker investor relationships on Novuson's behalf. Support remained advisory and materials-focused.

This boundary protects founder-owned investor relationships and keeps cap table narrative control with the company.